Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Immuneering Corp as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −12 vs. Q1 2022
- Shares held
- 12.1M
- −1.46M (−10.7%) vs. Q1 2022
- Total value
- $65.7M
- −$22.4M (−25.4%) vs. Q1 2022
- New holders
- 6
- 7 more added
- Sold out
- 18
- 21 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 4,142,829 | $22.4M | 0.00% | +577,356+16.2% | Added |
| Cormorant Asset Management, LP | 2,286,181 | $12.4M | 0.96% | −16,445−0.7% | Reduced |
| Citadel Advisors LLC | 2,199,209 | $11.9M | 0.02% | +39,777+1.8% | Added |
| BlackRock Inc. | 1,356,670 | $7.34M | 0.00% | −766,704−36.1% | Reduced |
| Vanguard Group Inc | 740,623 | $4.01M | 0.00% | −71,769−8.8% | Reduced |
| FMR LLC | 223,154 | $1.21M | 0.00% | +9,632+4.5% | Added |
| Buckingham Strategic Wealth, LLC | 200,200 | $1.08M | 0.02% | +200,200 | New |
| Suvretta Capital Management, LLC | 200,000 | $1.08M | 0.04% | 00.0% | Unchanged |
| TD Asset Management Inc | 147,661 | $799.0K | 0.00% | +26,460+21.8% | Added |
| Millennium Management LLC | 128,653 | $696.0K | 0.00% | +99,984+348.8% | Added |
| Adage Capital Partners GP, L.L.C. | 85,000 | $460.0K | 0.00% | −65,000−43.3% | Reduced |
| Manufacturers Life Insurance Company, The | 82,536 | $429.3K | 0.00% | −1,989−2.4% | Reduced |
| Geode Capital Management, LLC | 74,600 | $403.0K | 0.00% | −163,816−68.7% | Reduced |
| Kore Private Wealth LLC | 59,024 | $319.0K | 0.05% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 34,949 | $189.0K | 0.00% | +34,949 | New |
| Renaissance Technologies LLC | 25,537 | $138.0K | 0.00% | −32,063−55.7% | Reduced |
| State Street Corp | 25,035 | $135.0K | 0.00% | −151,445−85.8% | Reduced |
| Goldman Sachs Group Inc | 18,584 | $101.0K | 0.00% | +3,528+23.4% | Added |
| Morgan Stanley | 18,287 | $98.0K | 0.00% | −137−0.7% | Reduced |
| Two Sigma Investments, LP | 17,138 | $93.0K | 0.00% | −34,222−66.6% | Reduced |
| Cubist Systematic Strategies, LLC | 16,893 | $91.0K | 0.00% | −12,267−42.1% | Reduced |
| Qube Research & Technologies Ltd | 15,942 | $86.0K | 0.00% | +15,942 | New |
| Northern Trust Corp | 15,683 | $85.0K | 0.00% | −127,875−89.1% | Reduced |
| Two Sigma Advisers, LP | 11,100 | $60.0K | 0.00% | −2,200−16.5% | Reduced |
| Occudo Quantitative Strategies LP | 10,498 | $57.0K | 0.00% | +10,498 | New |
| Barclays PLC | 4,160 | $22.0K | 0.00% | −3,068−42.4% | Reduced |
| Tower Research Capital LLC (TRC) | 2,828 | $15.0K | 0.00% | +1,312+86.5% | Added |
| Legal & General Group Plc | 1,591 | $9.00K | 0.00% | −271−14.6% | Reduced |
| UBS Group AG | 1,401 | $8.00K | 0.00% | −1,862−57.1% | Reduced |
| JPMorgan Chase & Co | 1,133 | $6.00K | 0.00% | −10,836−90.5% | Reduced |
| Citigroup Inc | 929 | $6.00K | 0.00% | −599−39.2% | Reduced |
| Bank of America Corp | 891 | $4.00K | 0.00% | −28,413−97.0% | Reduced |
| New York State Common Retirement Fund | 165 | $1.00K | 0.00% | −4,472−96.4% | Reduced |
| Wells Fargo & Company | 55 | $0 | 0.00% | −9,838−99.4% | Reduced |
| Daiwa Securities Group Inc. | 76 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 10 | $0 | 0.00% | +10 | New |
| Ellevest, Inc. | 7 | $0 | 0.00% | +7 | New |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −681,051−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −70,127−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −48,431−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −45,441−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −27,047−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −19,300−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −14,625−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −14,272−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −13,819−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −10,442−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −9,432−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −8,124−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −8,249−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,900−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,219−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,167−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −634−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |